Pharmacies today aren’t just places to fill prescriptions. They’re healthcare gateways, vaccine distributors, insurance negotiators, and data engines. The answer depends on how you measure: revenue? Number of stores? Prescription volume? Patient reach? Each metric flips the leaderboard. I’m convinced that CVS leads in footprint and integration, but Walgreens isn’t far behind—and in some ways, it’s fighting smarter.
Defining “Largest”: Size Isn’t Just Square Footage
When people think “big pharmacy,” they imagine a neon-lit storefront with endless aisles. Reality? It’s logistics, insurance claims, and mail-order fulfillment centers the size of small towns. The real giants operate in the background, processing millions of transactions before lunch.
Revenue, number of locations, and prescription volume are the usual benchmarks. But even those don’t capture everything. For instance, a pharmacy chain might have fewer stores, yet handle more prescriptions through mail-order or digital platforms. Then there’s patient access—how many people live within 10 miles of a location? That’s where Walgreens edges out in urban density.
Revenue: The Financial Power Play
Caremark, the pharmacy benefit manager (PBM) under CVS Health, generated $458 billion in revenue in 2023. CVS retail clinics brought in another $35 billion. Compare that to Walgreens Boots Alliance’s $144 billion globally—impressive, but less than half. CVS Health ranks in the top five of the Fortune 500, ahead of Ford and Amazon.
But revenue alone doesn’t tell the full story. A portion of CVS’s income comes from insurance and health services, not just dispensing pills. That integration—pharmacy, PBM, insurance (via Aetna)—creates a vertical empire. It’s a bit like owning the farm, the truck, and the grocery store. And that’s exactly where the game gets distorted.
Physical Presence: Boots on the Ground
CVS operates 9,900 stores in the U.S. Walgreens has about 8,600. Rite Aid? Down to around 2,000 after bankruptcy and closures. But here’s the twist: Walgreens has a massive international footprint—130 stores in Thailand, 500 in Germany, and ownership of Alliance Healthcare, which supplies 340,000 pharmacies across Europe. So globally, Walgreens Boots Alliance touches more countries.
Yet, in the U.S.—the world’s largest pharmaceutical market—CVS wins on density. There are CVS stores in 50 states, including American Samoa. Some rural towns have only one pharmacy: it’s usually CVS. And that’s not by accident. Their expansion strategy targeted “pharmacy deserts” left behind by competitors.
Prescription Volume: Who Fills the Most Pills?
CVS fills approximately 1.3 billion prescriptions annually. Walgreens? Around 900 million. That gap is massive—equivalent to every person in India getting one free refill. But volume doesn’t equal efficiency. Walgreens processes more prescriptions per store on average, suggesting higher local demand or better staffing.
Mail-order is the silent driver. CVS’s Caremark handles 30% of all mail-order prescriptions in the U.S. That’s 270 million deliveries a year—many shipped from automated warehouses in Kentucky and Pennsylvania. Machines sort, label, and pack meds with barcode precision. Human pharmacists just verify. One facility can process 100,000 scripts a day.
The Role of Pharmacy Benefit Managers (PBMs)
PBMs are the hidden giants. They negotiate drug prices between insurers, manufacturers, and pharmacies. CVS owns Caremark. Walgreens owns part of Navitus (through a partnership). UnitedHealth owns Optum Rx. These three PBMs control over 80% of U.S. prescription spending.
Here’s where it gets murky. PBMs often charge “spread pricing”—they get rebates from drugmakers but don’t pass all savings to insurers or patients. A drug might cost $100 to the PBM, but they bill the insurer $140—and keep the $40 difference. Transparency? Not exactly their strong suit.
Patient Access and Healthcare Integration
CVS isn’t just selling Band-Aids and Benadryl. It’s pushing into primary care. MinuteClinics—now called “CVS HealthHubs”—offer blood pressure checks, flu shots, and even chronic care management. Over 1,100 are now open, with plans for 1,500 by 2025. Some are co-located with Signify Health, a home-care startup CVS acquired for $8 billion.
Walgreens is doing something different. Instead of building clinics, it partners with VillageMD, a primary care group. They’ve opened 400 clinics inside stores, with ambitions for 1,000. But Because VillageMD is independent, integration isn’t as tight as CVS’s in-house model. The issue remains: can partnerships deliver the same control as ownership?
Global Reach: Beyond U.S. Borders
If the question was “who has the most international influence?” Walgreens Boots Alliance wins hands down. Boots pharmacies in the UK are iconic—founded in 1849, they’re on nearly every high street. The company also owns Benavides in Mexico and has joint ventures in Japan and India.
Yet, international revenue doesn’t move the needle like the U.S. market. Boots UK generated £11 billion in 2023—about $14 billion. That’s less than 10% of Walgreens’ total revenue. Emerging markets are growing, but regulatory hurdles slow expansion. In China, for example, foreign ownership in pharmacies is restricted. So global presence is more symbolic than dominant.
And that’s exactly where conventional wisdom fails. People don’t think about this enough: the largest pharmacy isn’t defined by flags on a map. It’s about influence over drug pricing, patient data, and care delivery. In that arena, U.S.-based vertically integrated firms rule.
CVS vs. Walgreens: A Tale of Two Strategies
CVS is the bulldozer: acquire, integrate, scale. It bought Aetna to control insurance, Signify for home care, and Oak Street Health for senior clinics. Its goal? Keep patients within the CVS ecosystem from cradle to grave. This vertical integration is unprecedented in pharmacy.
Walgreens, meanwhile, is the strategist. It’s shrinking its U.S. store count but investing heavily in partnerships. The VillageMD alliance targets Medicare patients—60 million and growing. It’s a slower play, but potentially more sustainable. Unlike CVS, Walgreens hasn’t taken on massive debt for acquisitions. Which explains its more stable stock performance since 2020.
But—and this is a big but—partnerships can fall apart. UnitedHealth recently ended its pharmacy network deal with Walgreens. That means millions of patients now pay more to fill scripts there. As a result: Walgreens lost $10 billion in projected revenue over three years. CVS didn’t blink. It already had Caremark to absorb the shift.
Store Experience and Consumer Trust
Walk into a CVS and you’ll see health screens, Aetna kiosks, and shelves shrinking for snacks to make room for medical products. It’s clinical, efficient. Walgreens feels more like a convenience store—brighter, more cosmetics, more soda. To give a sense of scale: Walgreens sells more lipstick than any pharmacy chain. CVS sells more glucose monitors.
Consumer trust? A 2023 J.D. Power study gave Walgreens a slight edge in customer satisfaction. But CVS scored higher in prescription accuracy and wait times. There’s a trade-off: warmth vs. efficiency. You might like the cashier at Walgreens more, but you’ll probably get your meds faster at CVS.
Frequently Asked Questions
Is CVS the biggest pharmacy chain in the world?
In terms of U.S. stores and revenue, yes. CVS operates more locations and generates significantly higher income than any competitor. But globally, Walgreens Boots Alliance has a broader international presence, especially in Europe and parts of Asia. So we're far from it having a clear global monopoly.
What about online pharmacies? Could one overtake CVS?
Possibly. Amazon Pharmacy is small now—around 50 million prescriptions since launch—but it’s growing fast. With Prime delivery and price transparency, it’s a threat. But Amazon lacks physical clinics and PBM power. For now, it’s a niche player. Still, if they acquire a PBM? That changes everything.
Does the largest pharmacy offer the lowest prices?
Not necessarily. Large chains often have higher retail prices than independent pharmacies or warehouse clubs. Costco, for example, averages 20% lower on common generics. The thing is, size doesn’t always translate to savings for consumers. PBMs prioritize rebates and formulary placement over cash prices. Honestly, it is unclear whether competition actually lowers drug costs at the counter.
The Bottom Line
The largest pharmacy in the world is CVS Health—not because of shiny storefronts, but because it controls so much of the healthcare pipeline. It writes the prescriptions, runs the insurance, and delivers the medicine. That level of integration is unmatched. Walgreens is still a powerhouse, especially abroad, but it’s playing defense in the U.S.
I find this overrated: the idea that more stores equal more power. In healthcare, control over data and pricing beats real estate. My recommendation? Watch not the pharmacies, but the PBMs. They’re the puppeteers.
And here’s the irony: the biggest pharmacy doesn’t even look like a pharmacy. It looks like a server farm, a call center, and a clinic—all feeding a machine that dispenses profit as efficiently as pills. We’re not in Kansas anymore.